Sialyl Lewis X as a predictor of skip N2 metastasis in clinical stage IA non-small cell lung cancer

World Journal of Surgical Oncology

Volumn 11, Issue , 2013, Pages

  Komatsu, Hiroaki ^a   Mizuguchi, Shinjiro ^a   Izumi, Nobuhiro ^a   Chung, Kyukwang ^a   Hanada, Shoji ^a   Inoue, Hidetoshi ^a   Suehiro, Shigefumi ^a   Nishiyama, Noritoshi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Non small cell lung cancer; Prognosis; Sialyl Lewis X; Skip N2; Surgery

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; SIALYL LEWIS X ANTIGEN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BRONCHOSCOPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; HISTOLOGY; HUMAN; LUNG ADENOCARCINOMA; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; OVERALL SURVIVAL; PEROPERATIVE CARE; PREOPERATIVE CARE; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SURGICAL TECHNIQUE; SURVIVAL RATE; THORACOTOMY; TUMOR DIFFERENTIATION; TUMOR VOLUME;

AGED; ANTIGENS, NEOPLASM; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOLLOW-UP STUDIES; HUMANS; KERATIN-19; LUNG NEOPLASMS; MALE; NEOPLASM METASTASIS; NEOPLASM STAGING; OLIGOSACCHARIDES; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84889041116     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-11-309     Document Type: Article

References (40)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007, 57:43-66. 10.3322/canjclin.57.1.43, 17237035.
2. Goldstraw P, Crowley JJ, IASLC International Staging Project The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer. J Thorac Oncol 2006, 1:281-286. IASLC International Staging Project.
3. Fukui T, Mori S, Yokoi K, Mitsudomi T. Significance of number of positive lymph nodes in resected non-small cell lung cancer. J Thorac Oncol 2006, 1:120-125. 10.1097/01243894-200602000-00004, 17409840.
4. Naruke T, Tsuchiya R, Kondo H, Nakayama H, Asamura H. Lymph node sampling in lung cancer: how should it be done?. Eur J Cardiothorac Surg 1999, 16:S17-S24.
5. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995, 60:615-622. discussion 622-3, 10.1016/0003-4975(95)00537-U, 7677489.
6. Okada M, Tsutani Y, Ikeda T, Misumi K, Matsumoto K, Yoshimura M, Miyata Y. Radical hybrid video-assisted thoracic segmentectomy: long-term results of minimally invasive anatomical sublobar resection for treating lung cancer. Interact Cardiovasc Thorac Surg 2012, 14:5-11. 10.1093/icvts/ivr065, 3420301, 22108951.
7. Yamashita S, Tokuishi K, Anami K, Moroga T, Miyawaki M, Chujo M, Yamamoto S, Kawahara K. Thoracoscopic segmentectomy for T1 classification of non-small cell lung cancer: a single center experience. Eur J Cardiothorac Surg 2012, 42:83-88. 10.1093/ejcts/ezr254, 22228839.
8. Yamashita S, Chujo M, Kawano Y, Miyawaki M, Tokuishi K, Anami K, Yamamoto S, Kawahara K. Clinical impact of segmentectomy compared with lobectomy under complete video-assisted thoracic surgery in the treatment of stage I non-small cell lung cancer. J Surg Res 2011, 166:46-51. 10.1016/j.jss.2009.04.006, 19560164.
9. Yang CF, D'Amico TA. Thoracoscopic segmentectomy for lung cancer. Ann Thorac Surg 2012, 94:668-681. 10.1016/j.athoracsur.2012.03.080, 22748648.
10. Whitson BA, Groth SS, Andrade RS, Maddaus MA, Habermann EB, D'Cunha J. Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: a population-based analysis. Ann Thorac Surg 2011, 92:1943-1950. 10.1016/j.athoracsur.2011.05.091, 21962268.
11. Nakamura K, Saji H, Nakajima R, Okada M, Asamura H, Shibata T, Nakamura S, Tada H, Tsuboi M. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol 2010, 40:271-274. 10.1093/jjco/hyp156, 19933688.
12. Koike T, Koike T, Yamato Y, Yoshiya K, Toyabe S. Prognostic predictors in non-small cell lung cancer patients undergoing intentional segmentectomy. Ann Thorac Surg 2012, 93:1788-1794. 10.1016/j.athoracsur.2012.02.093, 22560265.
13. Zhong C, Fang W, Mao T, Yao F, Chen W, Hu D. Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer. Ann Thorac Surg 2012, 94:362-367. 10.1016/j.athoracsur.2012.04.047, 22727321.
14. Nomori H, Mori T, Izumi Y, Kohno M, Yoshimoto K, Suzuki M. Is completion lobectomy merited for unanticipated nodal metastases after radical segmentectomy for cT1 N0 M0/pN1-2 non-small cell lung cancer?. J Thorac Cardiovasc Surg 2012, 143:820-824. 10.1016/j.jtcvs.2011.10.045, 22104683.
15. Nomori H, Mori T, Ikeda K, Yoshimoto K, Iyama K, Suzuki M. Segmentectomy for selected cT1N0M0 non-small cell lung cancer: a prospective study at a single institute. J Thorac Cardiovasc Surg 2012, 144:87-93. 10.1016/j.jtcvs.2012.03.034, 22502969.
16. Moroga T, Yamashita S, Tokuishi K, Miyawaki M, Anami K, Yamamoto S, Kawahara K. Thoracoscopic segmentectomy with intraoperative evaluation of sentinel nodes for stage I non-small cell lung cancer. Ann Thorac Cardiovasc Surg 2012, 18:89-94. 10.5761/atcs.oa.11.01726, 22082811.
17. Prenzel KL, Mönig SP, Sinning JM, Baldus SE, Gutschow CA, Grass G, Schneider PM, Hölscher AH. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer. J Surg Oncol 2003, 82:256-260. 10.1002/jso.10219, 12672010.
18. Riquet M, Assouad J, Bagan P, Foucault C, Le Pimpec Barthes F, Dujon A, Danel C. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis. Ann Thorac Surg 2005, 79:225-233. 10.1016/j.athoracsur.2004.06.081, 15620948.
19. Gunluoglu Z, Solak O, Metin M, Gurses A. The prognostic significance of skip mediastinal lymphatic metastasis in resected non-small cell lung cancer. Eur J Cardiothorac Surg 2002, 21:595. 10.1016/S1010-7940(01)01135-6, 11888798.
20. Gawrychowski J, Gabriel A, Lackowska B. Heterogeneity of stage IIIA non-small cell lung cancers (NSCLC) and evaluation of late results of surgical treatment. Eur J Surg Oncol 2003, 29:178-184. 10.1053/ejso.2002.1321, 12633562.
21. Misthos P, Sepsas E, Athanassiadi K, Kakaris S, Skottis I. Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer. Eur J Cardiothorac Surg 2004, 25:502-508. 10.1016/j.ejcts.2004.01.025, 15037262.
22. Ilic N, Petricevic A, Arar D, Kotarac S, Banovic J, Ilic NF, Tripkovic A, Grandic L. Skip mediastinal nodal metastases in the in the IIIa/N2 non-small cell lung cancer. J Thorac Oncol 2007, 2:1018-1021. 10.1097/JTO.0b013e318158d471, 17975493.
23. Beasley MB, Brambilla E, Travis WD. The 2004 World Health Organization classification of lung tumors. Semin Roentgenol 2005, 40:90-97. 10.1053/j.ro.2005.01.001, 15898407.
24. Sobin LH, Gospodarowicz MK, Wittekind C. TMN Classification of Malignant Tumours 2009, Oxford: Wiley-Blackwell, 7.
25. Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P, Members of IASLC Staging Committee The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2009, 4:568-577. 10.1097/JTO.0b013e3181a0d82e, 19357537, Members of IASLC Staging Committee.
26. Kim S, Kim HK, Kang DY, Jeong JM, Choi YH. Intra-operative sentinel lymph node identification using a novel receptor-binding agent (technetium-99 m neomannosyl human serum albumin, 99mTc-MSA) in stage I non-small cell lung cancer. Eur J Cardiothorac Surg 2010, 37:1450-1456. 10.1016/j.ejcts.2010.01.012, 20353895.
27. Riquet M, Hidden G, Debesse B. Direct lymphatic drainage of lung segments to the mediastinal nodes. An anatomic study on 260 adults. J Thorac Cardiovasc Surg 1989, 97:623-632.
28. Asamura H, Nakayama H, Kondo H, Tsuchiya R, Naruke T. Lobe-specific extent of systematic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis. Thorac Cardiovasc Surg 1999, 117:1102-1111.
29. Matsuguma H, Yokoi K, Anraku M, Kondo T, Kamiyama Y, Mori K, Tominaga K, Tsuura Y, Honjo S. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: A predictor of lymph node metastasis. J Thorac Cardiovasc Surg 2002, 124:278-284. 10.1067/mtc.2002.122298, 12167787.
30. Suzuki K, Koike T, Asakawa T, Kusumoto M, Asamura H, Nagai K, Tada H, Mitsudomi T, Tsuboi M, Shibata T, Fukuda H, Kato H, Japan Lung Cancer Surgical Study Group (JCOG LCSSG) A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201). J Thorac Oncol 2011, 6:751-756. 10.1097/JTO.0b013e31821038ab, 21325976, Japan Lung Cancer Surgical Study Group (JCOG LCSSG).
31. Manac'h D, Riquet M, Medioni J, Le Pimpec-Barthes F, Dujon A, Danel C. Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor. Ann Thorac Surg 2001, 71:1088-1093. 10.1016/S0003-4975(00)02649-7, 11308141.
32. Yilmaz A, Duyar SS, Cakir E, Aydin E, Demirag F, Karakaya J, Yazici U, Erdogan Y. Clinical impact of visceral pleural, lymphovascular and perineural invasion in completely resected non-small cell lung cancer. Eur J Cardiothorac Surg 2011, 40:664-670.
33. Nishida K, Yamamoto H, Ohtsuki T, Matsuba M, Mukai S, Naito Y, Yoshikawa T, Kondo M. Elevated tissue concentrations of sialyl Lex-i in cancerous tissues compared with those in noncancerous tissues of various organs. Cancer 1991, 68:111-117. 10.1002/1097-0142(19910701)68:1<111::AID-CNCR2820680122>3.0.CO;2-E, 2049731.
34. Mizuguchi S, Nishiyama N, Iwata T, Nishida T, Izumi N, Tsukioka T, Inoue K, Uenishi T, Wakasa K, Suehiro S. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer. Lung Cancer 2007, 58:369-375. 10.1016/j.lungcan.2007.07.002, 17697728.
35. Mizuguchi S, Inoue K, Iwata T, Nishida T, Izumi N, Tsukioka T, Nishiyama N, Uenishi T, Suehiro S. High serum concentrations of Sialyl Lewisx predict multilevel N2 disease in non-small-cell lung cancer. Ann Surg Oncol 2006, 13:1010-1018. 10.1245/ASO.2006.05.018, 16788764.
36. Mizuguchi S, Nishiyama N, Iwata T, Nishida T, Izumi N, Tsukioka T, Inoue K, Kameyama M, Suehiro S. Clinical value of serum cytokeratin 19 fragment and sialyl-Lewis x in non-small cell lung cancer. Ann Thorac Surg 2007, 83:216-221. 10.1016/j.athoracsur.2006.08.042, 17184666.
37. Fukuoka K, Narita N, Saijo N. Increased expression of sialyl Lewis(x) antigen is associated with distant metastasis in lung cancer patients: immunohistochemical study on bronchofiberscopic biopsy specimens. Lung Cancer 1998, 20:109-116. 10.1016/S0169-5002(98)00016-6, 9711529.
38. Satoh H, Ishikawa H, Kamma H, Yamashita YT, Takahashi H, Ohtsuka M, Hasegawa S. Serum sialyl lewis X-i antigen levels in non-small cell lung cancer: correlation with distant metastasis and survival. Clin Cancer Res 1997, 3:495-499.
39. Satoh H, Ishikawa H, Kamma H, Yamashita YT, Takahashi H, Ohtsuka M, Hasegawa S. Elevated serum sialyl Lewis X-i antigen levels in non-small cell lung cancer with lung metastasis. Respiration 1998, 65:295-298. 10.1159/000029279, 9730796.
40. Inoue M, Takakuwa T, Minami M, Shiono H, Utsumi T, Kadota Y, Nasu T, Aozasa K, Okumura M. Clinicopathologic factors influencing postoperative prognosis in patients with small-sized adenocarcinoma of lung. J Thorac Cardiovasc Surg 2008, 135:830-836. 10.1016/j.jtcvs.2007.10.034, 18374763.